The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.

IF 2.3 Q2 RHEUMATOLOGY International Journal of Rheumatology Pub Date : 2019-05-05 eCollection Date: 2019-01-01 DOI:10.1155/2019/9698086
Tatiana M Reshetnyak, Irina A Doroshkevich, Natalia V Seredavkina, Evgeny L Nasonov, Igor V Maev, Vasiliy I Reshetnyak
{"title":"The Contribution of Drugs and <i>Helicobacter pylori</i> to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.","authors":"Tatiana M Reshetnyak,&nbsp;Irina A Doroshkevich,&nbsp;Natalia V Seredavkina,&nbsp;Evgeny L Nasonov,&nbsp;Igor V Maev,&nbsp;Vasiliy I Reshetnyak","doi":"10.1155/2019/9698086","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The nature and rate of gastric mucosal (GM) damage in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) remain to be among the unsolved problems.</p><p><strong>Objective: </strong>To define the role of <i>H. pylori</i> and drugs in the development of GM damages in SLE and APS.</p><p><strong>Methods: </strong>A study was conducted on 85 patients with SLE and APS. All the patients underwent esophagogastroduodenoscopy with targeted biopsy of the mucosa of the gastric body and antrum. The presence of <i>H. pylori</i> in the gastric biopsy specimens was determined using polymerase chain reaction.</p><p><strong>Results: </strong>Endoscopic examination revealed that the patients with SLE and APS on admission had the following GM changes: antral gastritis (82.4%), erosions (24.7%), hemorrhages (8.2%), and pangastritis (8.2%). SLE and APS patients showed no direct correlation between the found GM damages and the presence of <i>H. pylori</i>. The use of glucocorticoid, low-dose acetylsalicylic acid, nonsteroidal anti-inflammatory drug, and anticoagulant in SLE and APS patients is accompanied by GM damage.</p><p><strong>Conclusion: </strong>There was no evidence of the role of <i>H. pylori</i> in GM damage in the SLE and APS patients. More frequent detection of <i>H. pylori</i> was observed in anticoagulants or low-dose acetylsalicylic acid users than in glucocorticoids and nonsteroidal anti-inflammatory drugs ones.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2019-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/9698086","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/9698086","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 7

Abstract

Background: The nature and rate of gastric mucosal (GM) damage in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) remain to be among the unsolved problems.

Objective: To define the role of H. pylori and drugs in the development of GM damages in SLE and APS.

Methods: A study was conducted on 85 patients with SLE and APS. All the patients underwent esophagogastroduodenoscopy with targeted biopsy of the mucosa of the gastric body and antrum. The presence of H. pylori in the gastric biopsy specimens was determined using polymerase chain reaction.

Results: Endoscopic examination revealed that the patients with SLE and APS on admission had the following GM changes: antral gastritis (82.4%), erosions (24.7%), hemorrhages (8.2%), and pangastritis (8.2%). SLE and APS patients showed no direct correlation between the found GM damages and the presence of H. pylori. The use of glucocorticoid, low-dose acetylsalicylic acid, nonsteroidal anti-inflammatory drug, and anticoagulant in SLE and APS patients is accompanied by GM damage.

Conclusion: There was no evidence of the role of H. pylori in GM damage in the SLE and APS patients. More frequent detection of H. pylori was observed in anticoagulants or low-dose acetylsalicylic acid users than in glucocorticoids and nonsteroidal anti-inflammatory drugs ones.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
药物及幽门螺杆菌对系统性红斑狼疮及抗磷脂综合征患者胃黏膜变化的影响。
背景:系统性红斑狼疮(SLE)和抗磷脂综合征(APS)患者胃粘膜(GM)损伤的性质和发生率仍是尚未解决的问题之一。目的:探讨幽门螺杆菌和药物在SLE和APS患者GM损伤发展中的作用。方法:对85例SLE合并APS患者进行研究。所有患者均行食管胃十二指肠镜检查,并对胃体和胃窦粘膜进行有针对性的活检。采用聚合酶链反应测定胃活检标本中幽门螺杆菌的存在。结果:内镜检查显示,SLE合并APS患者入院时GM变化为:胃窦性胃炎(82.4%)、糜烂(24.7%)、出血(8.2%)、胃脘炎(8.2%)。SLE和APS患者发现的GM损伤与幽门螺杆菌的存在没有直接关系。SLE和APS患者使用糖皮质激素、低剂量乙酰水杨酸、非甾体类抗炎药和抗凝血药时伴有GM损伤。结论:没有证据表明幽门螺杆菌在SLE和APS患者GM损伤中的作用。抗凝血剂或低剂量乙酰水杨酸使用者幽门螺杆菌检出率高于糖皮质激素和非甾体抗炎药使用者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.40
自引率
0.00%
发文量
9
审稿时长
24 weeks
期刊最新文献
An Observational Study on the Clinical Characteristics and Prognosis of Patients With Interstitial Lung Disease Secondary to Dermatomyositis and Antisynthetase Syndrome. Exploring the Psychiatric Manifestations of Primary Sjögren’s Syndrome: A Narrative Review Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy. Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities Association of Cytokine IL-17, IL-4, IL-6, and IL-12 Gene Polymorphisms in Rheumatoid Arthritis Patients in a Tertiary Care Hospital in Bangladesh.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1